PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) TARGETED BIO-ORTHOGONAL THERAPY FOR METASTATIC PROSTATE CANCER

$1,188,835FY2016Department of the ArmyDOD

The Johns Hopkins University

Investigators